EUVIMEDEUVIMED entdecken
Crossref

Pulse versus non‐pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis

Kwonhyung Hyung, Jong Hyuk Lee, Joong-Yub Kim, Sun Mi Choi iD, Jimyung Park iD

Respirology · 2024-03 · 29 (3) · 235-242

DOI: 10.1111/resp.14643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respirology, online erschienen am 12.12.2023. Verfasst von Kwonhyung Hyung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Idiopathic Interstitial Pneumonias, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Corticosteroids are commonly used for the treatment of acute exacerbation of idiopathic pulmonary fibrosis (AE‐IPF); however, the optimal initial dose of corticosteroids remains uncertain due to a lack of sufficient evidence. We evaluated whether the administration of a pulse dose of corticosteroids resulted in improved survival outcomes compared with conventional non‐pulse dose of corticosteroids.

Methods

We retrospectively analysed 238 patients with AE‐IPF treated with corticosteroids at a tertiary referral hospital between January 2013 and December 2021. Based on whether a pulse dose of corticosteroids (methylprednisolone of ≥250 mg/day or equivalent) was administered within 7 days of hospitalization for AE‐IPF, the patients were divided into the pulse and non‐pulse regimen groups. The survival outcomes were compared between the two groups using multivariable regression and propensity score‐matched analyses.

Results

Among the 238 patients, 59 patients received pulse dose of corticosteroids, whereas 179 patients received conventional non‐pulse dose of corticosteroids. After adjusting for the confounding factors related to the baseline clinical and radiographic severity, compared with the conventional non‐pulse regimen, the pulse regimen of corticosteroids did not reduce the risk of mortality at the 3‐month (aHR 0.84, 95% CI 0.45–1.38) or 12‐month (aHR 0.96, 95% CI 0.60–1.25) follow‐ups. Propensity score‐matched analysis revealed similar results.

Conclusion

The survival outcomes of patients with AE‐IPF who received a pulse dose of corticosteroids did not differ from those of patients who received conventional non‐pulse dose of corticosteroids. Further prospective studies are required to establish the optimal initial dose of corticosteroids for the treatment of AE‐IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Interstitial PneumoniasIdiopathic Pulmonary FibrosisHumansDisease ProgressionRetrospective StudiesTreatment OutcomeAdrenal Cortex Hormones

Stichwörter der Autor:innen

acute exacerbationcohort studyglucocorticoididiopathic pulmonary fibrosispulse corticosteroid therapy symptom flare up

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.

ORCID-Profile: Sun Mi Choi, Jimyung Park

Zitieren

APA

Hyung, K., Lee, J. H., Kim, J. Y., Choi, S. M., & Park, J. (2024). Pulse versus non‐pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respirology, 29(3), 235-242. https://doi.org/10.1111/resp.14643

Vancouver

Hyung K, Lee JH, Kim JY, Choi SM, Park J. Pulse versus non‐pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respirology. 2024;29(3):235-242. doi:10.1111/resp.14643

BibTeX
@article{Hyung2024,
  author = {Hyung, Kwonhyung and Lee, Jong Hyuk and Kim, Joong-Yub and Choi, Sun Mi and Park, Jimyung},
  title = {Pulse versus non‐pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis},
  journal = {Respirology},
  year = {2024},
  volume = {29},
  number = {3},
  pages = {235--242},
  doi = {10.1111/resp.14643}
}
Kostenlos starten →